Unknown

Dataset Information

0

A Short Peptide That Mimics the Binding Domain of TGF-?1 Presents Potent Anti-Inflammatory Activity.


ABSTRACT: The transforming growth factor beta 1 (TGF-?1) is a pleiotropic cytokine with multiple roles in development, wound healing, and immune regulation. TGF-?1-mediated immune dysfunction may lead to pathological conditions, such as inflammation. Chronic inflammatory process is characterized by a continuous release of pro-inflammatory cytokines, and the inhibition or the blockage of these cytokines signaling pathways are considered a target treatment. In this context, despite the high numbers of TGF-?-targeted pathways, the inducible regulatory T cells (iTreg) to control inflammation seems to be a promising approach. Our aim was to develop novel peptides through phage display (PhD) technology that could mimic TGF-?1 function with higher potency. Specific mimetic peptides were obtained through a PhD subtraction strategy from whole cell binding using TGF-?1 recombinant as a competitor during elution step. We have selected a peptide that seems to play an important role on cellular differentiation and modulation of TNF-? and IL-10 cytokines. The synthetic pm26TGF-?1 peptide tested in PBMC significantly down-modulated TNF-? and up-regulated IL-10 responses, leading to regulatory T cells (Treg) phenotype differentiation. Furthermore, the synthetic peptide was able to decrease leukocytes rolling in BALB/C mice and neutrophils migration during inflammatory process in C57BL/6 mice. These data suggest that this peptide may be useful for the treatment of inflammatory diseases, especially because it displays potent anti-inflammatory properties and do not exhibit neutrophils' chemoattraction.

SUBMITTER: Vaz ER 

PROVIDER: S-EPMC4552549 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications


The transforming growth factor beta 1 (TGF-β1) is a pleiotropic cytokine with multiple roles in development, wound healing, and immune regulation. TGF-β1-mediated immune dysfunction may lead to pathological conditions, such as inflammation. Chronic inflammatory process is characterized by a continuous release of pro-inflammatory cytokines, and the inhibition or the blockage of these cytokines signaling pathways are considered a target treatment. In this context, despite the high numbers of TGF-β  ...[more]

Similar Datasets

| S-EPMC4619319 | biostudies-literature
| S-EPMC3491551 | biostudies-literature
| S-EPMC10322889 | biostudies-literature
| S-EPMC9254699 | biostudies-literature
| S-EPMC7221121 | biostudies-literature
| S-EPMC5603911 | biostudies-literature
| S-EPMC4932631 | biostudies-literature
| S-EPMC4653649 | biostudies-literature
| S-EPMC9154745 | biostudies-literature
| S-EPMC4445658 | biostudies-literature